Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Healthcare Services Group | HCSG | Apr 17, 2024 | 11.58 | -0.17 |
Healthcare Triangle | HCTI | Apr 17, 2024 | 1.32 | -5.04 |
Healthcare Trust A Pref | HTIA | Apr 17, 2024 | 15.15 | +0.52 |
Healthcare Trust B Pref | HTIBP | Apr 17, 2024 | 14.40 | -3.07 |
HealthEquity | HQY | Apr 17, 2024 | 79.87 | -0.50 |
Healthpeak Properties | DOC | Apr 17, 2024 | 18.07 | +1.40 |
HealthStream | HSTM | Apr 17, 2024 | 24.47 | -0.81 |
Heartcore Enterprises | HTCR | Apr 17, 2024 | 0.93 | +14.86 |
Heartland Express | HTLD | Apr 17, 2024 | 10.34 | -0.96 |
Heartland Financial E Pref | HTLFP | Apr 17, 2024 | 24.67 | -0.72 |
Heartland Financial USA | HTLF | Apr 17, 2024 | 33.01 | -0.87 |
HeartSciences | HSCS | Apr 17, 2024 | 0.10 | -2.88 |
Hecla Mining | HL | Apr 17, 2024 | 5.28 | +0.38 |
Hecla Mining B Pref | HL-B | Apr 17, 2024 | 52.79 | 0.00 |
Hedge Replication ETF Proshares | HDG | Apr 17, 2024 | 48.54 | -0.13 |
Heico | HEI | Apr 17, 2024 | 197.55 | -0.40 |
Heico A | HEI-A | Apr 17, 2024 | 160.06 | -0.25 |
Heidrick & Struggles International | HSII | Apr 17, 2024 | 29.42 | -1.31 |
Helen of Troy | HELE | Apr 17, 2024 | 96.15 | -2.15 |
Helios Technologies | HLIO | Apr 17, 2024 | 46.01 | +0.57 |
Helius Medical Technologies A | HSDT | Apr 17, 2024 | 5.18 | -2.63 |
Helix Acquisition II | HLXB | Apr 17, 2024 | 10.34 | 0.00 |
Helix Energy Solutions Group | HLX | Apr 17, 2024 | 10.69 | -1.66 |
Hello ADR | MOMO | Apr 17, 2024 | 5.52 | -0.72 |
Helmerich & Payne | HP | Apr 17, 2024 | 40.85 | -0.85 |
Hempacco | HPCO | Apr 17, 2024 | 0.98 | -1.99 |
Hennessy Advisors | HNNA | Apr 17, 2024 | 6.92 | -0.79 |
Hennessy Capital Investment VI SPAC A | HCVI | Apr 17, 2024 | 10.49 | +0.29 |
Hennessy Capital Investment VI Unit | HCVIU | Apr 17, 2024 | 11.46 | +9.56 |
Henry Schein | HSIC | Apr 17, 2024 | 70.20 | -1.43 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.